Glucantime-resistant visceral leishmaniasis in immunocompromised patients.
Verdejo
J
J
Alvar
J
J
Polo
R M
RM
González-Lahoz
J M
JM
D000965:Antimony; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D006801:Humans; D007108:Immune Tolerance; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D008536:Meglumine / Q000627:therapeutic use*; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000627:therapeutic use*; D013012:Sorbitol / Q000031:analogs & derivatives*
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D013012:Sorbitol; D008536:Meglumine; D000077485:Meglumine Antimoniate; D000965:Antimony